NRAS and acute myeloid leukemia: NPM1 and N-RAS double mutant transgenic mice (Npm1cA/+; NrasG12D/+) developed high penetrance, enhanced self-renewal capacity in hematopoietic progenitors, and AML-like myeloid differentiation bias [193].